In summary, our results showed that visfatin -1535C>T polymorphisms were related to a significantly reduced risk of HBV-HCC, and the genotype TT and the allele T may be the protective factors for HBV-HCC among the ethnic Zhuang population in Guangxi, China. The gene discussed is NAMPT; the disease is hepatocellular carcinoma.